Tianjin State Key Laboratory of Modern Chinese Medicine, Chinese Materia Medica College, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
PLoS One. 2012;7(4):e35636. doi: 10.1371/journal.pone.0035636. Epub 2012 Apr 24.
Small molecules have been shown to modulate the neurogenesis processes. In search for new therapeutic drugs, the herbs used in traditional medicines for neurogenesis are promising candidates.
We selected a total of 45 natural compounds from Traditional Chinese herbal medicines which are extensively used in China to treat stroke clinically, and tested their proliferation-inducing activities on neural stem/progenitor cells (NSPCs). The screening results showed that salvianolic acid B (Sal B) displayed marked effects on the induction of proliferation of NSPCs. We further demonstrated that Sal B promoted NSPCs proliferation in dose- and time-dependent manners. To explore the molecular mechanism, PI3K/Akt, MEK/ERK and Notch signaling pathways were investigated. Cell proliferation assay demonstrated that Ly294002 (PI3K/Akt inhibitor), but neither U0126 (ERK inhibitor) nor DAPT (Notch inhibitor) inhibited the Sal B-induced proliferation of cells. Western Blotting results showed that stimulation of NSPCs with Sal B enhanced the phosphorylation of Akt, and Ly294002 abolished this effect, confirming the role of Akt in Sal B mediated proliferation of NSPCs. Rats exposed to transient cerebral ischemia were treated for 4 weeks with Sal B from the 7th day after stroke. BrdU incorporation assay results showed that exposure Sal B could maintain the proliferation of NSPCs after cerebral ischemia. Morris water maze test showed that delayed post-ischemic treatment with Sal B improved cognitive impairment after stroke in rats.
Sal B could maintain the NSPCs self-renew and promote proliferation, which was mediated by PI3K/Akt signal pathway. And delayed post-ischemic treatment with Sal B improved cognitive impairment after stroke in rats. These findings suggested that Sal B may act as a potential drug in treatment of brain injury or neurodegenerative diseases.
小分子已被证明可调节神经发生过程。在寻找新的治疗药物时,传统医学中用于神经发生的草药是很有前途的候选药物。
我们从广泛用于中国临床治疗中风的传统中药中选择了总共 45 种天然化合物,并测试了它们对神经干细胞/祖细胞(NSPC)的增殖诱导活性。筛选结果表明,丹酚酸 B(Sal B)对 NSPC 增殖的诱导具有明显作用。我们进一步证明 Sal B 以剂量和时间依赖的方式促进 NSPC 增殖。为了探讨分子机制,研究了 PI3K/Akt、MEK/ERK 和 Notch 信号通路。细胞增殖实验表明,Ly294002(PI3K/Akt 抑制剂),而 U0126(ERK 抑制剂)和 DAPT(Notch 抑制剂)均不抑制 Sal B 诱导的细胞增殖。Western Blotting 结果表明,Sal B 刺激 NSPCs 增强了 Akt 的磷酸化,而 Ly294002 消除了这种作用,证实了 Akt 在 Sal B 介导的 NSPCs 增殖中的作用。从中风后第 7 天开始,将 Sal B 用于短暂性脑缺血大鼠 4 周的治疗。BrdU 掺入实验结果表明,暴露于 Sal B 可维持 NSPCs 在脑缺血后的增殖。Morris 水迷宫测试表明,延迟性脑缺血后给予 Sal B 可改善大鼠中风后的认知障碍。
Sal B 可通过 PI3K/Akt 信号通路维持 NSPCs 的自我更新和促进增殖。延迟性脑缺血后给予 Sal B 可改善大鼠中风后的认知障碍。这些发现表明 Sal B 可能作为一种治疗脑损伤或神经退行性疾病的潜在药物。